Ongoing Phase 2 Agents for Multiple Sclerosis: Could We Break the Phase 3 Trial Deadlock? Silvia Susin-Calle, Jose Enrique Martinez-Rodriguez,Elvira Munteis,Pablo VillosladaExpert opinion on investigational drugs(2025)引用 0|浏览1AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要